Cipher Pharma (fka CPH:TSX)

[ADVFN_bioking]

APPROVEDDDDDDD

Cipher Pharmaceuticals Receives Health Canada Approval For Trulance® (Plecanatide)
https://finance.yahoo.com/news/cipher-pharmaceuticals-receives-health-canada-110000703.html

It is estimated that one in four Canadians has symptoms of constipation and an estimated 38% of Canadians report constipation within the previous 12 months1. According to IQVIA the total Canadian laxative and antispasmodic market (prescription and OTC) was valued at over CDN $200 million for the 12 months ending December 2018 .

[ADVFN_bioking]

nice jump ,,2 approvals around the corner likely before or on october 15

[ADVFN_bioking]

3-4 Weeks then drug approvals likely to come in .. this low float stock could double quickly.GL

[ADVFN_bioking]

Both attractive drugs below could be approved by health canada within next month which could push this low float stock significantly higher ...

Cipher Pharmaceuticals Announces A-101 40% Topical Solution Accepted for Review by Health Canada....Dec. 18, 2018
https://cipher.investorroom.com/2018-12-18-Cipher-Pharmaceuticals-Announces-A-101-40-Topical-Solution-Accepted-for-Review-by-Health-Canada


Cipher Pharmaceuticals Announces PLECANATIDE Accepted for Review by Health Canada....Dec. 17, 2018
https://cipher.investorroom.com/2018-12-17-Cipher-Pharmaceuticals-Announces-PLECANATIDE-Accepted-for-Review-by-Health-Canada

[ADVFN_bioking]

Strong insider buying in last days and many big milestones coming before year end ..Great buying opportunity here

https://www.canadianinsider.com/node/7?menu_tickersearch=CPH+%7C+Cipher+Pharmaceuticals

Cipher anticipates several key milestones in 2019 that will continue the growth of its Canadian commercial platform, including:

*Regulatory approval for plecanatide from Health Canada in Q4 2019

*Regulatory approval for A-101 from Health Canada in Q4 2019

*Commercial launch of XYDALBA (dalbavancin)

*North American top line results for MOB-015 in Q4 2019

[PINKYXXX]

First